Complete morphologic response to gilteritinib in ALK-rearranged acute myeloid leukemia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Complete morphologic response to gilteritinib in ALK-rearranged acute myeloid leukemia ; volume:8 ; number:1 ; day:10 ; month:9 ; year:2024 ; pages:1-6 ; date:12.2024
npj precision oncology ; 8, Heft 1 (10.9.2024), 1-6, 12.2024
- Urheber
-
Adashek, Jacob J.
Brodsky, Max
Levis, Mark J.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41698-024-00701-y
- URN
-
urn:nbn:de:101:1-2411242113031.801706602955
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Adashek, Jacob J.
- Brodsky, Max
- Levis, Mark J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Clinical outcomes in ALK-rearranged lung adenocarcinomas according to ALK fusion variants
FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia
Double and single mixed-lineage leukemia-rearranged subclones in pediatric acute myeloid leukemia: a case report
Targeting YAP to overcome acquired resistance to ALK inhibitors in ALK ‐rearranged lung cancer
Impact of blood count recovery on outcomes of acute myeloid leukemia patients achieving morphologic leukemia-free state
Gingival Metastasis of ALK Rearranged Non-Small Cell Lung Cancer
Successful Treatment of a Resistant Subclone in ALK-Rearranged NSCLC
RNA binding proteins in MLL-rearranged leukemia
The epigenetic regulators EP300/CREBBP represent promising therapeutic targets in MLL-rearranged acute myeloid leukemia
Concurrent acute myeloid leukemia and T lymphoblastic lymphoma in a patient with rearranged PDGFRB genes
Delineating the role of programmed cell death 4 in Mixed Lineage Leukemia-rearranged acute myeloid leukemia using RNA interference
The ALK inhibitor AZD3463 effectively inhibits growth of sorafenib-resistant acute myeloid leukemia
Clinical outcomes in ALK-rearranged lung adenocarcinomas according to ALK fusion variants
FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia
Double and single mixed-lineage leukemia-rearranged subclones in pediatric acute myeloid leukemia: a case report
Targeting YAP to overcome acquired resistance to ALK inhibitors in ALK ‐rearranged lung cancer
Impact of blood count recovery on outcomes of acute myeloid leukemia patients achieving morphologic leukemia-free state
Gingival Metastasis of ALK Rearranged Non-Small Cell Lung Cancer
Successful Treatment of a Resistant Subclone in ALK-Rearranged NSCLC
RNA binding proteins in MLL-rearranged leukemia
The epigenetic regulators EP300/CREBBP represent promising therapeutic targets in MLL-rearranged acute myeloid leukemia
Concurrent acute myeloid leukemia and T lymphoblastic lymphoma in a patient with rearranged PDGFRB genes
Delineating the role of programmed cell death 4 in Mixed Lineage Leukemia-rearranged acute myeloid leukemia using RNA interference
The ALK inhibitor AZD3463 effectively inhibits growth of sorafenib-resistant acute myeloid leukemia
Clinical outcomes in ALK-rearranged lung adenocarcinomas according to ALK fusion variants
FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia
Double and single mixed-lineage leukemia-rearranged subclones in pediatric acute myeloid leukemia: a case report
Targeting YAP to overcome acquired resistance to ALK inhibitors in ALK ‐rearranged lung cancer
Impact of blood count recovery on outcomes of acute myeloid leukemia patients achieving morphologic leukemia-free state
Gingival Metastasis of ALK Rearranged Non-Small Cell Lung Cancer
Successful Treatment of a Resistant Subclone in ALK-Rearranged NSCLC
RNA binding proteins in MLL-rearranged leukemia
The epigenetic regulators EP300/CREBBP represent promising therapeutic targets in MLL-rearranged acute myeloid leukemia
Concurrent acute myeloid leukemia and T lymphoblastic lymphoma in a patient with rearranged PDGFRB genes
Delineating the role of programmed cell death 4 in Mixed Lineage Leukemia-rearranged acute myeloid leukemia using RNA interference